The Relationship Between Time Perspective, Fear of Cancer Recurrence, Rumination, and Catastrophizing in Gastric Cancer Survivors

The Formation Pathway of Fear of Cancer Recurrence in Gastric Cancer Survivors From a Time Perspective

The temporal perspective provides a theory oriented to temporal insights that can shed light on the role of cognitive coping styles in the formation of fear of cancer recurrence. The self-regulatory executive function model elucidates the central role of rumination thinking, catastrophizing cognitive coping styles in the formation of cancer recurrence fear. Therefore, this study will rely on both theoretical models to construct a cognitive appraisal coping model to explore the formation pathway of cancer recurrence fear

Study Overview

• Status: Completed
• Conditions: Gastric Cancer Patient

• Study Type: Observational
• Enrollment (Actual): 340

Contacts and Locations

Study Locations

• China
  • Jiangsu
    • Nanjing, Jiangsu, China, 21116
      • Jiangsu

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult; Older Adult
• Accepts Healthy Volunteers: N/A

• Sampling Method: Probability Sample

Study Population

Select elderly gastric cancer patients who were receiving medical treatment at a tertiary hospital

Description

Inclusion Criteria:

• Preoperative gastroscopy and pathological diagnosis of gastric cancer;
• Aged 18 years or older
• There is no history of recurrent disease or new primary cancer
• Received surgical resection of cancerous tissues or radiotherapy treatment
• Conscious, with normal communication and comprehension ability
• The patients were aware of their own condition and diagnosis, and informedly agreed to participate in this study

Exclusion Criteria:

● History of mental or cognitive impairment prior to cancer diagnosis

Study Plan

How is the study designed?

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Time perspective	The Chinese version of ZIPI scale was adopted for the measurement of time perspective, ZIPI scale is the current international common measurement tool.ZTPI scale was developed by Zimbardo et al. in 1999, which is mainly used for assessing individual's time perspective, the scale has been translated by scholars from many countries, and has good cross-cultural applicability. The Chinese version of the ZTPI scale was Chineseized and revised by Wang Chen in 2016, and the revised scale can be divided into five dimensions of past negativity (7 entries), past positivity (6 entries), present impulsivity (4 entries), future (5 entries), and present predestination (3 entries), with a total of 25 entries after exploratory factor analysis.All questions are scored on a scale of 1 (strongly disagree) to 5 (strongly agree), with higher scores indicating a greater tendency towards certain time perspective.	through study completion, an average of 1 year
Catastrophizing	Catastrophizing was measured using the 4-item Cognitive Emotion Regulation Questionnaire Catastrophizing subscale ( CERQ-CS ). Chinese scholars such as Zhu Xiongzhao (2007) revised the Cognitive Emotion Regulation Questionnaire (CERQ) to form the Chinese version of the Cognitive Emotion Regulation Questionnaire (CERQ-C) applicable to the Chinese version.Each item of the CERQ - CS has 5 responses ranging from 1 (almost never) to 5 (almost always). Higher total scores on this subscale indicate higher levels of catastrophizing, and this subscale has good reliability in the Chinese population, the minimum value is 4 points, and the maximum value is 20 points	through study completion, an average of 1 year
Rumination	Intrusive rumination was measured using the Event-Related Rumination Rumination Questionnaire (ERRI). It is scored according to how many rumination the subjects have produced in the last two weeks and the number of scores is used to assess the degree of rumination of the individual. It was revised by Zhou Xiao et al. (2014) to Cann et al.'s (2010) Event-Related Rumination Questionnaire, which included two dimensions of intrusive rumination and active rumination, with a total of 20 questions. After the revision, the questionnaire had good internal consistency coefficients for the total and dimensions, and the validity indicators also reached a good level. Each item is rated on a 4 point scale, and the scores of the Intrusive rumination scales range from 0 to 30 points The higher the score, the higher the level of invasive rumination.	through study completion, an average of 1 year
Fear of cancer recurrence	The Chinese version of the Fear of Disease Progression Simplified Scale (FoP-Q-SF) was used to measure the degree of fear of recurrence in cancer patients. Our researchers and scholars, Wu Qiyun et al. translated and Chineseized the FoP-Q-SF according to Chinese characteristics to form a version of the Fear of Progression of Disease Simplified Scale suitable for cancer patients in China. There are 12 questions in total, the higher the score, the higher the level of fear of recurrence. When the score is between 12 and 23, it indicates that the patient is at a low level of fear recurrence. When the score is between 24 and 36, it indicates that the patient is at a moderate level of fear recurrence. When the score is between 36 and 60, it indicates that the patient is at a high level of fear recurrence.	through study completion, an average of 1 year

Collaborators and Investigators

• Sponsor: Ting Wang

Study record dates

Study Major Dates

• Study Start (Actual): August 10, 2023
• Primary Completion (Actual): September 1, 2024
• Study Completion (Actual): September 10, 2024

Study Registration Dates

• First Submitted: September 17, 2024
• First Submitted That Met QC Criteria: September 18, 2024
• First Posted (Actual): September 20, 2024

Study Record Updates

• Last Update Posted (Actual): September 20, 2024
• Last Update Submitted That Met QC Criteria: September 18, 2024
• Last Verified: September 1, 2024

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Digestive System Diseases; Pathologic Processes; Neoplasms; Neoplasms by Site; Disease Attributes; Gastrointestinal Neoplasms; Digestive System Neoplasms; Gastrointestinal Diseases; Stomach Diseases; Stomach Neoplasms; Recurrence
• Other Study ID Numbers: 2023540

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No